Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
about
A novel cysteine-rich sequence-specific DNA-binding protein interacts with the conserved X-box motif of the human major histocompatibility complex class II genes via a repeated Cys-His domain and functions as a transcriptional repressorMapping functional regions in the lumenal domain of the class II-associated invariant chainModeling T cell antigen discrimination based on feedback control of digital ERK responsesCross-Reactivity of TCR Repertoire: Current Concepts, Challenges, and Implication for AllotransplantationDefinition of an HLA-DPw2-restricted epitope on NS3, recognized by a dengue virus serotype-cross-reactive human CD4+ CD8- cytotoxic T-cell cloneStructural features of a zinc binding site in the superantigen strepococcal pyrogenic exotoxin A (SpeA1): Implications for MHC class II recognitionExploration of the P6/P7 region of the peptide-binding site of the human class II major histocompatability complex protein HLA-DR1Bidirectional binding of invariant chain peptides to an MHC class II moleculeSusceptibility to HLA-DM Protein Is Determined by a Dynamic Conformation of Major Histocompatibility Complex Class II Molecule Bound with PeptideImmunoproteomics: Mass spectrometry-based methods to study the targets of the immune responseAchieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expressionHLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responsesAggregation of human recombinant monoclonal antibodies influences the capacity of dendritic cells to stimulate adaptive T-cell responses in vitroSlc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigensDefective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expressionStructural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide bindingSelective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pHThe segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptidesEditing of the HLA-DR-peptide repertoire by HLA-DMNitration of the pollen allergen bet v 1.0101 enhances the presentation of bet v 1-derived peptides by HLA-DR on human dendritic cellsA novel type of class I gene organization in vertebrates: a large family of non-MHC-linked class I genes is expressed at the RNA level in the amphibian XenopusInvariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1Determining the breadth of the respiratory syncytial virus-specific T cell responseT cell memory to evolutionarily conserved and shared hemagglutinin epitopes of H1N1 viruses: a pilot scale study.The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.Contribution of mass spectrometry to contemporary immunology.HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptideHuman CD4+ T cell epitopes from vaccinia virus induced by vaccination or infectionEmploying a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective.Systematic characterisation of cellular localisation and expression profiles of proteins containing MHC ligands.T cell receptor repertoire in rheumatoid arthritis.Rous-Whipple Award Lecture. Chemical features of peptide selection by the class II histocompatibility molecules.An expanded self-antigen peptidome is carried by the human lymph as compared to the plasma.Lymphocyte responses to DR1/4 restricted peptides in rheumatoid arthritis.Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides.Truncation of the class II beta-chain cytoplasmic domain influences the level of class II/invariant chain-derived peptide complexes.Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway.Intracellular transport and peptide loading of MHC class II molecules: regulation by chaperones and motors.Mechanisms and consequences of peptide selection by the I-Ak class II molecule.Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.
P2860
Q24337320-B9A53C02-6B16-4495-A70B-6389721BE126Q24679667-7D774A41-D2CB-4B7B-A18C-2D800062633BQ24814731-3FE0A970-A9BE-47B6-BB6D-2AAAF5BE5827Q26752289-8DE35BB4-2427-42F5-A209-42555F8861F4Q27486071-90473B58-FA1B-44EC-A4F2-7990B2DBDA84Q27631880-078B5932-8DB2-41E2-8714-4F71CD060DBEQ27641946-AE4ECE48-6888-461C-A356-384CEA4E7534Q27666102-31676AA5-6425-49C4-A859-ED0C16036F31Q27684590-C6A413D0-A237-4CEF-9A9C-744BBE94E86EQ28238379-E72BE291-B105-46C8-AAE1-4EFE732C89F8Q28273723-DFB928CB-B6EF-4023-AB44-DC900D10EC6FQ28473871-D128DF3A-2A47-4368-B21F-EFB4C1912CA3Q28538936-7ED03E03-742E-469B-893F-C45280A7AAF8Q28585423-E8537F80-B73E-4AA1-BD1D-7F8A86941EDCQ28585705-2787F96D-9BB8-4F68-AAD8-D8034592B49BQ28612873-7A7EEA82-700E-404B-B13A-8C41EA28CEC2Q28612958-5059B55A-9185-41D8-A8F2-338572AE7C0AQ28613064-EF137DD9-901C-4F90-A4B5-5E71180178C2Q28613148-B3FF0FFD-0BB7-48F2-BD9A-F39AB542A519Q28732106-78391DE0-7C65-4042-87D4-371815065D8FQ28775861-4C8F59E5-5A2C-4759-9A1E-12A30879EBBAQ28776057-F79F0CD1-F79B-48A1-9B86-A6BCF9C7C48FQ30411070-EA5C1EA1-2B28-45DE-9B90-489ED3B4B7C9Q30430123-EF5AC899-A17E-4BA8-95B5-D40C7E6BD151Q30444065-1BC8FA08-13C3-4C99-80C9-5D4E21D3B6F2Q30697033-474EFD03-763B-4386-893E-233FBF14F9A7Q33292091-7E5FA4A3-B4C7-44E8-8423-7FB7CF92607DQ33302672-EC2A3969-3929-48B2-B4CF-9F0DC39ABF23Q33506224-46215C79-7297-4CAD-A6E0-A646E03F390CQ33510342-A4EE8871-E1F7-4A18-9BE1-8641959F052FQ33536195-C4E5989C-B43E-4B4D-AB0F-0B6F6F1A66B1Q33541540-D42A2AD9-4F2E-439E-8AF4-F9A2FE506898Q33548677-80410664-0326-4C71-A3F4-BBE58F93B31AQ33566179-576E36F2-81CD-46B1-A436-616210F4F8A1Q33575103-8DBC5F4F-6402-42F3-AA68-883B403C286FQ33613002-3882B26C-B9EB-4331-ACD7-EC4C65F64524Q33766466-9D864ABF-48C3-45E7-BC29-5A8807A70AFEQ33815425-6A987EFC-F54D-4A96-B03A-A30FB912D47CQ33815430-AB2A1980-3390-479F-926D-C09C5050DD8FQ33844495-FA0F57EB-0B36-48C5-8E26-64AB528CE59F
P2860
Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Predominant naturally processe ...... and are heterogeneous in size.
@en
Predominant naturally processe ...... and are heterogeneous in size.
@nl
type
label
Predominant naturally processe ...... and are heterogeneous in size.
@en
Predominant naturally processe ...... and are heterogeneous in size.
@nl
prefLabel
Predominant naturally processe ...... and are heterogeneous in size.
@en
Predominant naturally processe ...... and are heterogeneous in size.
@nl
P2093
P356
P1433
P1476
Predominant naturally processe ...... and are heterogeneous in size.
@en
P2093
P2888
P304
P356
10.1038/358764A0
P407
P577
1992-08-01T00:00:00Z
P6179
1022407102